Olink Holding AB (publ) – NASDAQ:OLK
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 13 hours
Olink Holding AB (publ) stock price monthly change
+5.80%
month
Olink Holding AB (publ) stock price quarterly change
+11.45%
quarter
Olink Holding AB (publ) stock price yearly change
+45.86%
year
Olink Holding AB (publ) key metrics
Market Cap | 3.24B |
Enterprise value | 2.53B |
P/E | -216.7 |
EV/Sales | 18.11 |
EV/EBITDA | 1402.04 |
Price/Sales | 18.58 |
Price/Book | 6.32 |
PEG ratio | -3.25 |
EPS | -0.27 |
Revenue | 171.44M |
EBITDA | -33.39M |
Income | -33.69M |
Revenue Q/Q | 4.12% |
Revenue Y/Y | 18.54% |
Profit margin | -9.19% |
Oper. margin | -21.88% |
Gross margin | 67.57% |
EBIT margin | -21.88% |
EBITDA margin | -19.48% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOlink Holding AB (publ) stock price history
Olink Holding AB (publ) stock forecast
Olink Holding AB (publ) financial statements
| Jun 2023 | 29.43M | -8.27M | -28.11% |
|---|---|---|---|
| Sep 2023 | 44.15M | -1.81M | -4.12% |
| Dec 2023 | 69.26M | -7.62M | -11.01% |
| Mar 2024 | 28.58M | -15.97M | -55.87% |
| Dec 2023 | 69.26M | -7.62M | -11.01% |
|---|---|---|---|
| Mar 2024 | 28.58M | -15.97M | -55.87% |
| Sep 2025 | 61.29M | -1.24M | -2.03% |
| Dec 2025 | 91.31M | 21.55M | 23.6% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 530499000 | 60M | 11.31% |
|---|---|---|---|
| Sep 2023 | 552825000 | 80.72M | 14.6% |
| Dec 2023 | 602267089 | 99.55M | 16.53% |
| Mar 2024 | 542939771 | 81.32M | 14.98% |
| Jun 2023 | -16.85M | -3.76M | -612K |
|---|---|---|---|
| Sep 2023 | -15.59M | -6.30M | -787K |
| Dec 2023 | -3.03M | -9.61M | -754K |
| Mar 2024 | -6.74M | -1.50M | -815.36K |
Olink Holding AB (publ) alternative data
| Aug 2023 | 582 |
|---|---|
| Sep 2023 | 667 |
| Oct 2023 | 667 |
| Nov 2023 | 667 |
| Dec 2023 | 582 |
| Jan 2024 | 582 |
| Feb 2024 | 582 |
| Mar 2024 | 707 |
| Apr 2024 | 707 |
| May 2024 | 707 |
| Jun 2024 | 707 |
| Jul 2024 | 707 |
Olink Holding AB (publ) other data
17.37%
-17.86%
of OLK is owned by hedge funds
30
-22
20.68M
-14.28M
shares is hold by hedge funds
| Quarter | Transcript |
|---|---|
| Q2 2023 12 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
When is Olink Holding AB (publ)'s next earnings date?
Unfortunately, Olink Holding AB (publ)'s (OLK) next earnings date is currently unknown.
-
Does Olink Holding AB (publ) pay dividends?
No, Olink Holding AB (publ) does not pay dividends.
-
How much money does Olink Holding AB (publ) make?
Olink Holding AB (publ) has a market capitalization of 3.24B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 21.49% to 169.91M US dollars.
-
What is Olink Holding AB (publ)'s stock symbol?
Olink Holding AB (publ) is traded on the NASDAQ under the ticker symbol "OLK".
-
What is Olink Holding AB (publ)'s primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Olink Holding AB (publ)?
Shares of Olink Holding AB (publ) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Olink Holding AB (publ) have?
As Jul 2024, Olink Holding AB (publ) employs 707 workers.
-
When Olink Holding AB (publ) went public?
Olink Holding AB (publ) is publicly traded company for more then 4 years since IPO on 26 Mar 2021.
-
What is Olink Holding AB (publ)'s official website?
The official website for Olink Holding AB (publ) is olink.com.
-
How can i contact Olink Holding AB (publ)?
Olink Holding AB (publ) can be reached via phone at +46 18 444 39 70.
Olink Holding AB (publ) company profile:
Olink Holding AB (publ)
olink.comExchange:
NASDAQ
Full time employees:
707
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data. Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.
Uppsala Science Park
Uppsala, 751 83
Uppsala, 751 83
CIK: 0001835539
ISIN: US6807101000
CUSIP: 680710100
